Equities

IFR US ECM Calendar

 |  Stephen Lacey

January 8: Aktis Oncology (US, biotech) ─ $212m IPO. 11.8m shares (Primary) at $16-$18. JPM, BOFA, LEER, TDC. Nasdaq "AKTS".

Topics
Equity Capital Marketed Follow-Ons Americas North America United States US Dollar Structured Equity ABBs and Block Trades Initial Public Offerings (IPO)
Issuers
Aktis Oncology Inc